Search results
Singapore. We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible.
Contact Form. This contact is provided as a service and is not intended for the notification of adverse events and medical issues. If your comments concern personal health conditions, medical issues or related to Sanofi prescription products, you should consult your healthcare professional.
Jul 4, 2022 · French pharmaceutical company Sanofi will build a new state-of-the-art vaccine manufacturing facility, named Evolutive Vaccine Facility (EVF), in Singapore for the large-scale manufacturing of vaccines to enhance preparedness for future pandemics.
Apr 20, 2022 · French pharmaceutical giant Sanofi had announced last year that it would invest €400 million (S$637.8 million) in a new vaccine production site in Singapore. Sanofi's APAC regional headquarters...
Apr 20, 2022 · SINGAPORE - French pharmaceutical giant Sanofi broke ground on Wednesday (April 20) on its state-of-the-art vaccine facility in Singapore, which will allow it to quickly pivot to making new...
Apr 12, 2021 · Sanofi announced a €400 million investment over five years to create a unique vaccine production center in Singapore, pushing the boundaries of operations through cutting edge manufacturing and digital technologies.
SINGAPORE -- French drugmaker Sanofi plans to bring its new vaccine plant in Singapore fully online by the end of 2025 as it looks to tap growing demand for preventive care in an aging Asia. A...
Apr 12, 2021 · SINGAPORE - Pharmaceutical giant Sanofi Pasteur is investing €400 million (S$638 million) over five years to build a vaccine production centre in Singapore, giving a boost to the Republic's...
Apr 20, 2022 · Sanofi’s EVF is the latest addition to Singapore’s biopharma ecosystem. Here in Singapore, we have the active ingredients to help biopharma companies grow and contribute to the region. Let me name three of them – scale, innovation, and talent.
Sanofi broke ground on its Evolutive Vaccine Facility (EVF) in Singapore today, in the presence of Singapore’s Deputy Prime Minister and Coordinating Minister for Economic Policies, Heng Swee Keat, and Sanofi’s Executive Vice President, Head of Vaccines, Thomas Triomphe.
